✦ LIBER ✦

Safe and successful ERCP in the billroth II (B-II) gastroenterostomy patient: Impact of recent advances

✍ Scribed by Qaseem, T.; Howell, D.A.; Parsons, W.G.; Bosco, J.J.

Book ID: 122443690
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 156 KB
Volume: 43
Category: Article
ISSN: 1097-6779
DOI: 10.1016/S0016-5107(96)80404-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Success and complications of 224 ERCP'S

Success and complications of 224 ERCP'S in billroth-II (B-II) patients: A 5 year review

✍ AB Elfant; MJ Bourke; R Alhalel; P Kortan; GB Haber 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Which scope and which technique will enh

Which scope and which technique will enhance the success rate in ERCP for the Billroth II patient?

✍ Sandro Mosca 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

5-Fluorouracil and Allopurinol Combined

5-Fluorouracil and Allopurinol Combined with Recombinant Interferon-alpha 2b in the Treatment of Patients with Advanced Prostate Cancer: A Phase I/II Study

✍ Glazier, David B.; Heaney, John A.; Amdur, Robert J.; Schned, Alan R.; Harris, R 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 401 KB

P-403 Vatalanib in patients with previou

P-403 Vatalanib in patients with previously untreated advanced malignant mesothelioma (MM): Preliminary analysis of a phase II study by the Cancer and Leukemia Group B (CALGB 30107)

✍ Jahan, T.; Gu, L.; Wang, X.; Kratzke, R.; Green, M.; Vokes, E.; Kindler, H. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

[Studies in Surface Science and Catalysi

[Studies in Surface Science and Catalysis] Recent Advances in the Science and Technology of Zeolites and Related Materials Part B, Proceedings of the 14th International Zeolite Conference Volume 154 || IR X-ray and thermal studies on zeolite-13X and its Mn(II) and Zn(II) exchange and adsorbed derivatives

✍ D., Mishra 📂 Article 📅 2004 🏛 Elsevier 🌐 English ⚖ 586 KB

413 Phase II study evaluating the effica

413 Phase II study evaluating the efficacy, safety and pharmacodynamic correlative study of dual anti-angiogenic inhibition using Bevacizumab (B) in combination with Sorafenib (S) in patients (pts) with advanced malignant melanoma

✍ D. Mahalingam; M. Beeram; J. Rodon; K. Sankhala; A. Mita; D. Benjamin; J. Michal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB